Skip to main content

Health & Wellbeing

All health is public health

All health is public health: Busting the myths of choice and commodity

For decades, we have been sold a myth of private health. It is a myth that our health is largely a product of individual choices and personal responsibilities. It is a myth that our healthcare is a service that private corporations can provide, and for which we must pay to survive. read more
Doctor at work

Primary health care is in critical condition. Making primary care public will restore its health—and protect ours

To avoid the catastrophic effects on our health and our economy of hollowing out our primary care system, the U.S. should create a national program for universal public primary care. read more
Public pharmaceutical

Public pharmaceuticals

Public pharmaceutical enterprises are free from the constraints of profit maximization and can define their bottom line based on such values as their contributions to public health and local economic resiliency. read more
Biomed Europa

Biomed Europa: A challenge to the pharmaceutical oligopoly

In his new white paper, “Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly,” Italian economist Massimo Florio proposes an international, transparent, public phar read more
Pharmacist holding medicines

Four steps toward reclaiming public medicine for public health

Now is the time to redesign our medicines system around open science practices, full-cycle public pharmaceutical production, compulsory licensing, and public ownership of the vaccine industry. read more

Stories

VA for all

Create a “VA for all” 

In our lifetime, it has perhaps never been clearer that we need a single, coordinated public healthcare system with equal access for all—a read more

System Change magazine highlights a year of bold ideas

The Democracy Collaborative and the Next System Project has published System Change, a magazine that captures the bold ideas and groundbreaking work of our leaders and scholars in 2019. read more
A blister pack of medicine in pill form

Commitments to public pharmaceutical production in the Democratic primary

Our report Medicine For All: The Case for a Public Option in the Pharmaceutical Industry  argues that truly making pharmaceuticals accessible and affordable for all Americans will require public ownership of pharmaceutical production read more
A pipette being dipped into an array of testtubes

A National Pharmaceutical Research and Development Institute

To promote the execution of pharmaceutical R&D in the public interest, the US should establish a national pharmaceutical R&D institute for full-cycle drug development, which will help promote long-term access to medicines, reignite innovation, and ensure prioritization of public health needs. read more